Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Peter Kuehl, Jiong Zhang, Yvonne Lin et al. · Nature Genetics · 2001 · 2.2K citations

Life Sciences, Genetics, Molecular Biology +17

The genetic determinants of the CYP3A5 polymorphism

Elisabeth Hustert, Michael Haberl, Oliver Burk et al. · Pharmacogenetics · 2001 · 670 citations

Medicine, Genetics, Molecular Genetics +13

Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7

J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell et al. · Drug Metabolism and Disposition · 2002 · 468 citations

Medicine, Biochemistry, Pharmacology +17

RESPONSE: Re: Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4

B. Amirimani, AH Walker, BL Weber et al. · JNCI Journal of the National Cancer Institute · 1999 · 465 citations

Medicine, Genetics, Oncology +16

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily

Jack Gorski, Stephen D. Hall, D. I. Jones et al. · Biochemical Pharmacology · 1994 · 397 citations

Medicine, Medicinal Chemistry, Pharmacology +12